Editas Medicine, Inc. (EDIT) Stock Price History
Historical prices from 2016 to 2026
Loading 10-year price history...
EDIT Historical Performance
Short-Term Returns
EDIT Stock Price Trajectory (2016–2026)
As of May 7, 2026, Editas Medicine, Inc. (EDIT) trades at $3.18, representing a +138.7% return over the past year. The stock has delivered a -90.8% total return over five years (-37.9% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $99.95 on January 8, 2021. From this peak, EDIT has corrected -96.8%, currently trading 20% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers CRSP (+66.1% 1Y), BEAM (+102.2% 1Y), and NTLA (+91.0% 1Y), EDIT has outperformed the peer group average. Compare EDIT vs CRSP →
EDIT Historical Price Data (2016–2026)
Showing 30 of 2,580 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-06 | 3.10 | 3.18 | 3.04 | 3.17 | 795K | +4.44% |
| 2026-05-05 | 3.12 | 3.16 | 2.92 | 3.04 | 1.25M | +1.33% |
| 2026-05-04 | 2.88 | 3.08 | 2.88 | 3.00 | 600K | +3.45% |
| 2026-05-01 | 2.98 | 2.98 | 2.84 | 2.90 | 777K | -3.33% |
| 2026-04-30 | 2.82 | 3.06 | 2.82 | 3.00 | 1.13M | +6.38% |
| 2026-04-29 | 3.00 | 3.06 | 2.77 | 2.82 | 1.21M | -7.84% |
| 2026-04-28 | 2.88 | 3.08 | 2.85 | 3.06 | 1.27M | +5.88% |
| 2026-04-27 | 2.85 | 3.12 | 2.81 | 2.89 | 1.73M | -0.69% |
| 2026-04-24 | 3.21 | 3.21 | 2.88 | 2.91 | 1.50M | -9.35% |
| 2026-04-23 | 3.30 | 3.38 | 3.14 | 3.21 | 1.12M | -3.60% |
| 2026-04-22 | 3.33 | 3.46 | 3.27 | 3.33 | 1.09M | +0.91% |
| 2026-04-21 | 3.58 | 3.59 | 3.25 | 3.30 | 1.60M | -7.56% |
| 2026-04-20 | 3.41 | 3.65 | 3.37 | 3.57 | 1.81M | +2.29% |
| 2026-04-17 | 3.47 | 3.56 | 3.36 | 3.49 | 1.63M | +4.18% |
| 2026-04-16 | 3.35 | 3.40 | 3.22 | 3.35 | 1.37M | -0.59% |
| 2026-04-15 | 3.40 | 3.58 | 3.33 | 3.37 | 1.56M | -0.59% |
| 2026-04-14 | 3.29 | 3.55 | 3.23 | 3.39 | 2.31M | +5.94% |
| 2026-04-13 | 2.94 | 3.26 | 2.89 | 3.20 | 2.39M | +8.84% |
| 2026-04-10 | 2.92 | 2.95 | 2.79 | 2.94 | 1.58M | +1.73% |
| 2026-04-09 | 2.75 | 2.92 | 2.71 | 2.89 | 1.33M | +4.71% |
| 2026-04-08 | 2.92 | 2.94 | 2.67 | 2.76 | 1.06M | +0.73% |
| 2026-04-07 | 2.69 | 2.76 | 2.56 | 2.74 | 1.54M | +0.74% |
| 2026-04-06 | 2.66 | 2.82 | 2.64 | 2.72 | 1.91M | +1.87% |
| 2026-04-02 | 2.54 | 2.69 | 2.53 | 2.67 | 1.11M | +2.30% |
| 2026-04-01 | 2.52 | 2.75 | 2.50 | 2.61 | 2.05M | +5.67% |
| 2026-03-31 | 2.25 | 2.52 | 2.25 | 2.47 | 1.84M | +10.76% |
| 2026-03-30 | 2.23 | 2.27 | 2.13 | 2.23 | 1.75M | 0.00% |
| 2026-03-27 | 2.27 | 2.29 | 2.17 | 2.23 | 1.64M | -3.88% |
| 2026-03-26 | 2.28 | 2.48 | 2.24 | 2.32 | 1.69M | 0.00% |
| 2026-03-25 | 2.29 | 2.38 | 2.29 | 2.32 | 1.02M | +3.11% |
See EDIT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EDIT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EDIT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEDIT — Frequently Asked Questions
Quick answers to the most common questions about buying EDIT stock.
How has EDIT stock performed recently?
EDIT returned +138.7% over the past year, beating its 5-year annualized CAGR of -37.9%. The stock trades above its 200-day moving average, confirming the uptrend.
What is EDIT's all-time high price?
Editas Medicine, Inc. reached $99.95 on 2021-01-08. The 52-week high is $4.54. Current 1-year return of +138.7% places the stock closer to historical peaks.
Where can I download EDIT historical price data?
This page provides EDIT daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.